Indications and uses
for the temporary relief of minor aches, and pains of muscles and joints associated with simple backache, arthritis, strains, bruises and sprains.
Kay Medic Menthol Pain Relief Cream
- Manufacturer
- Kay Medic LLC
- Effective date
- 2017-02-08
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:20:01
Label at a glance#
ProductKay Medic Menthol Pain Relief
Active ingredientMENTHOL
Label structure11 sections
Dosage and administration
Adults and children 12 years of age or older: apply to affected area not more than 3 or 4 times daily. Children under 12 years of age: ask a doctor before use.
Contacts and useful links#
Label contents#
Full prescribing information#
ACTIVE INGREDIENTS
Menthol 3.00%
PURPOSE
External Analgesic
USES
for the temporary relief of minor aches, and pains of muscles and joints associated with simple backache, arthritis, strains, bruises and sprains.
WARNINGS
- For external use only. Avoid contact with eyes, nose, mouth and genitalia.
- Use only as directed.
- Do not apply to open wounds or damaged skin.
- Do no bandage tightly
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have sensitive skin.
Keep out of reach of children.
If swallowed, contact your local poision control center or emergency room immediately.
OTC - STOP USE SECTION
If symptoms persist for more than seven days, discontinue use and consult physician.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast feeding, contact physcian prior to use.
DIRECTIONS:
Adults and children 12 years of age or older: apply to affected area not more than 3 or 4 times daily.
Children under 12 years of age: ask a doctor before use.
OTHER INGREDIENTS
Acorus Calamus (Sweet Flag/Shi Chang Pu) Rhizome Extract,Aloe Barbadensis Leaf Extract (Aloe Vera Gel), Angelica Dahurica Root Extract, Angelica Sinensis Root Tip Extract, Aqua (Deionized Water), Arisaema(Jack-In The-Pulpit) Rhizome Processed With Bovine Bile (Bile Arisaema/Dan Nan Xing) Extract; Bis-Vinyl Dimethicone/Dimethicone Copolymer; Boswellia Sacra (Frankincense/Olivanum) Resin; Cancer Irroratus (Atlantic Rock Crab) Carapace Extract; Carthamus Tinctorius (Safflower) Extract; Cetyl Alcohol; Chondroitin Sulfate; Cimicifuga Racemosa (Climicifuga) Root Extract; Commiphora Myrrha Resin Extract;Cyclopentasiloxane; Dracaena Cinnabari (Dragon's Blood) Resin Extract;Fossilized Mammals Bones ("Dragon" Bones/Long Gu) Extract; Glucosamine Sulfate; Glycerin; Glyceryl Stearate, Ledebouriella Divaricata (Ledebouriella/Fang Feng) Root Extract; Ligusticum Wallichii (Szechuan Lovage/Chuanxiong) Root Extract; Methylsulfinylmethane (Msm); Notopterygium Incisum (Notopterygium) Root Extract; Peg-100 Stearate; Peg-12 Dimethicone; Phenoxyethanol; Polysorbate-20; Propylene Glycol; Stearic Acid; Strychnos Nux-Vomica (Strychnine Tree/Yanhusuo) Extract.
Pakage Labeling
KAY MEDIC
MENTHOL PAIN RELIEF CREAM
1oz. (29.5735mL)
Manufactured for Kay Medic LLC, Davie, Florida, 33331 USA
Questions or comments? Call 1-888-217-8628 (English)
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| MENTHOL | ACTIVE INGREDIENT | L7T10EIP3A | 1 | |
| MENTHOL | ACTIVE MOIETY | L7T10EIP3A | 1 | |
| ACORUS CALAMUS ROOT | INACTIVE INGREDIENT | XY1K7KIQ0F | 1 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| ANGELICA DAHURICA ROOT | INACTIVE INGREDIENT | 1V63N2S972 | 1 | |
| ANGELICA SINENSIS ROOT | INACTIVE INGREDIENT | B66F4574UG | 1 | |
| ARISAEMA ERUBESCENS ROOT | INACTIVE INGREDIENT | 3E8P1PU8SY | 1 | |
| ATLANTIC ROCK CRAB | INACTIVE INGREDIENT | 2K19902G3Q | 1 | |
| BLACK COHOSH | INACTIVE INGREDIENT | K73E24S6X9 | 1 | |
| CARTHAMUS TINCTORIUS (SAFFLOWER) OLEOSOMES | INACTIVE INGREDIENT | 9S60Q72309 | 1 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 1 | |
| CHONDROITIN SULFATE (BOVINE) | INACTIVE INGREDIENT | 6IC1M3OG5Z | 1 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) | INACTIVE INGREDIENT | 9E4CO0W6C5 | 1 | |
| DIMETHYL SULFOXIDE | INACTIVE INGREDIENT | YOW8V9698H | 1 | |
| FRANKINCENSE | INACTIVE INGREDIENT | R9XLF1R1WM | 1 | |
| GLUCOSAMINE SULFATE | INACTIVE INGREDIENT | 1FW7WLR731 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERYL STEARATE SE | INACTIVE INGREDIENT | FCZ5MH785I | 1 | |
| LIGUSTICUM WALLICHII ROOT | INACTIVE INGREDIENT | R81AD159QS | 1 | |
| MAMMAL BONE, FOSSILIZED | INACTIVE INGREDIENT | 0N1T3913DA | 1 | |
| MYRRH | INACTIVE INGREDIENT | JC71GJ1F3L | 1 | |
| NOTOPTERYGIUM INCISUM ROOT | INACTIVE INGREDIENT | 5Z2WW4J6RI | 1 | |
| PEG-100 STEARATE | INACTIVE INGREDIENT | YD01N1999R | 1 | |
| PEG-12 DIMETHICONE (300 CST) | INACTIVE INGREDIENT | ZEL54N6W95 | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| POLYSORBATE 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| STRYCHNOS NUX-VOMICA WHOLE | INACTIVE INGREDIENT | AB2NX17POS | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Kay Medic Menthol Pain Relief
- MENTHOL
- ACORUS CALAMUS ROOT
- ALOE VERA LEAF
- ANGELICA DAHURICA ROOT
- ANGELICA SINENSIS ROOT
- WATER
- ARISAEMA ERUBESCENS ROOT
- DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE)
- FRANKINCENSE
- ATLANTIC ROCK CRAB
- CARTHAMUS TINCTORIUS (SAFFLOWER) OLEOSOMES
- CETYL ALCOHOL
- CHONDROITIN SULFATE (BOVINE)
- BLACK COHOSH
- MYRRH
- CYCLOMETHICONE 5
- MAMMAL BONE, FOSSILIZED
- GLUCOSAMINE SULFATE
- GLYCERIN
- GLYCERYL STEARATE SE
- LIGUSTICUM WALLICHII ROOT
- DIMETHYL SULFOXIDE
- NOTOPTERYGIUM INCISUM ROOT
- PEG-100 STEARATE
- PEG-12 DIMETHICONE (300 CST)
- PHENOXYETHANOL
- POLYSORBATE 20
- PROPYLENE GLYCOL
- STEARIC ACID
- STRYCHNOS NUX-VOMICA WHOLE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 69542-555 | 69542-555-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 120 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / SUBCUTANEOUS | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SOAP / TOPICAL | 6 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / ORAL | 29008 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | TABLET, FILM COATED / ORAL | NA | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | EMULSION / TOPICAL | 2 %w/w | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | GEL / TOPICAL | 5 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / VAGINAL | 1225 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LOTION, AUGMENTED / TOPICAL | 2070 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | SOLUTION / TOPICAL | 15 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / INTRAMUSCULAR | 1.62 %w/v | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | SOLUTION / TOPICAL | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / RECTAL | 3315 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SOLUTION / SUBCUTANEOUS | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | EMULSION / OPHTHALMIC | 1.5 %w/v | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | SOAP / TOPICAL | 0.02 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 60 mg | ||
| GLYCERYL STEARATE SE | GLYCERYL STEARATE SE | FCZ5MH785I | LOTION / TOPICAL | 46 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET / ORAL | 64 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | POWDER, FOR SUSPENSION / ORAL | 1203 mg/5ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUPPOSITORY / VAGINAL | 252 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL / TOPICAL | 19.2 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / DENTAL | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, DELAYED RELEASE / ORAL | 36 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / OPHTHALMIC | 0.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | OINTMENT / TOPICAL | 7 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAVENOUS | 4000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / OPHTHALMIC | 1 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / INTRAVENOUS | 5 %w/v | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 72 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / TOPICAL | 5.28 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM / BUCCAL | 1.48 mg | ||
| DIMETHYL SULFOXIDE | DIMETHYL SULFOXIDE | YOW8V9698H | SOLUTION / TOPICAL | 8008 mg | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | LOTION / TOPICAL | 1 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT, AUGMENTED / TOPICAL | 714 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | CAPSULE / ORAL | 563 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / AURICULAR (OTIC) | 56.55 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / TOPICAL | 5148 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 59 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | TABLET / ORAL | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, DELAYED RELEASE / ORAL | 80 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | CAPSULE, DELAYED RELEASE / ORAL | 59 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 07244b2d-bf6c-03b6-e063-6394a90a6340 | 00e64e31-e674-4d8f-9b68-a14b7002386f | 2023-10-07 | Warnings | 00e64e31-e674-4d8f-9b68-a14b7002386f |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.